A Morbidity-Mortality and Remodeling Study With Valsartan

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.
Epistemonikos ID: d555756c60a0c3ca1172a48f272c527b6393d302
First added on: Dec 19, 2015